复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书

智通财经10-31

智通财经APP讯，复旦张江(01349)发布公告，该公司的附属公司泰州复旦张江药业有限公司(泰州复旦张江)收到国家药品监督管理局(国家药监局)核准签发的《受理通知书》，奥贝胆酸片(规格：5mg、10mg)(该药物)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。该药物属于法尼酯 X 受体(Farnesoid X receptor，FXR)激动剂。FXR 是一种在肝脏和肠道中高水平表达的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2479771323?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-31 16:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2479771323","market":"sh","top_or_hot":-1,"title":"复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，复旦张江(01349)发布公告，该公司的附属公司泰州复旦张江药业有限公司(泰州复旦张江)收到国家药品监督管理局(国家药监局)核准签发的《受理通知书》，奥贝胆酸片(规格：5mg、10mg)(该药物)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。该药物属于法尼酯 X 受体(Farnesoid X receptor，FXR)激动剂。FXR 是一种在肝脏和肠道中高水平表达的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1204893.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复旦张江(01349)：奥贝胆酸片用于治疗原发性胆汁性胆管炎获得药物上市申请受理通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-31 16:55 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1204893.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，复旦张江(01349)发布公告，该公司的附属公司泰州复旦张江药业有限公司(泰州复旦张江)收到国家药品监督管理局(国家药监局)核准签发的《受理通知书》，奥贝胆酸片(规格：5mg、10mg)(该药物)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。该药物属于法尼酯 X 受体(Farnesoid X receptor，FXR)激动剂。FXR 是一种在肝脏和肠道中高水平表达的...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1204893.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1204893.html","article_id":"2479771323","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2479771323","pubTimestamp":1730364948,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，复旦张江 发布公告，该公司的附属公司泰州复旦张江药业有限公司收到国家药品监督管理局核准签发的《受理通知书》，奥贝胆酸片(该药物)用于治疗原发性胆汁性胆管炎的药物上市申请获得受理。该药物是化学药品 3 类仿制药，其首个目标适应症为原发性胆汁性胆管炎。集团对于原研药物的专利限制进行了突破，并在中国大陆获得了相应的专利授权。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688505":"复旦张江","BK0239":"医药制造","BK1191":"制药","01349":"复旦张江"},"translate_title":"Fudan Zhangjiang (01349): Obeticholic acid tablets for the treatment of primary biliary cholangitis received a drug marketing application acceptance notice","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688505":1,"01349":1},"content_text":"智通财经APP讯，复旦张江(01349)发布公告，该公司的附属公司泰州复旦张江药业有限公司(泰州复旦张江)收到国家药品监督管理局(国家药监局)核准签发的《受理通知书》，奥贝胆酸片(规格：5mg、10mg)(该药物)用于治疗原发性胆汁性胆管炎(PBC)的药物上市申请获得受理。该药物属于法尼酯 X 受体(Farnesoid X receptor，FXR)激动剂。FXR 是一种在肝脏和肠道中高水平表达的核受体，在胆酸代谢调节中起关键性作用。该药物是化学药品 3 类仿制药，其首个目标适应症为原发性胆汁性胆管炎。中国作为肝胆疾病高发的国家，市场容量非常庞大。集团对于原研药物的专利限制进行了突破，并在中国大陆获得了相应的专利授权。2021年3月15日，国家卫健委联合科技部、工业和信息化部、国家医保局、国家药监局、国家知识产权局六部门，组织专家对国内专利即将到期尚未提出注册申请及临床供应短缺(竞争不充分)的药品进行遴选论证，制定了《第二批鼓励仿制药品目录》，明确了鼓励仿制的十七种药品及剂型，其中包括奥贝胆酸片。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2479771323"}